AHCO - Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga
Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings.
KMX reported a third-quarter sales decline of 5.5% year-on-year to $6.15 billion, missing the analyst consensus estimate of $6.33 billion. EPS of $0.52 beat the consensus estimate of $0.44.
CarMax shares climbed 7.7% to $80.42 on Thursday.
Here are some other stocks moving in today's mid-day session.
Gainers
- Infrared Cameras Holdings Inc (NASDAQ: MSAI) shares jumped 222% to $8.43 after falling over 61% on Wednesday.
- HOOKIPA Pharma Inc. (NASDAQ: HOOK) surged 75% to $0.9874 after the company announced a $21.25 million equity investment from Gilead Sciences.
- DMK Pharmaceuticals Corporation (NASDAQ: DMK) shares climbed 50.8% to $0.8899. DMK Pharmaceuticals regained full rights to commercialize ZIMHI after the termination of an exclusive commercialization and distribution with US WorldMeds, LLC.
- PetVivo Holdings, Inc. (NASDAQ: PETV) shares rose 41.3% to $1.20.
- ParaZero Technologies Ltd. (NASDAQ: PRZO) shares climbed 37.4% to $1.6904 after the company appointed Nir Ben Moshe, a former senior director in the Israeli Ministry of Defense, as a specialist advisor.
- Annexon, Inc. (NASDAQ: ANNX) gained 34.7% to $3.88. Annexon outlined its global registrational program for ANX007 for the treatment of patients with geographic atrophy. The company also reported pricing of $125 million public offering of common stock.
- Triumph Group, Inc. (NYSE: TGI) rose 27% to $15.59 after the company entered into a definitive agreement with AAR to sell its Product Support business.
- Aurora Technology Acquisition Corp.. (NASDAQ: ATAK) shares gained 26.3% to $5.57 after falling 15% on Wednesday.
- Galiano Gold Inc. (NYSE: GAU) rose 23.5% to $0.8130 as the company announced that it has entered into a binding share purchase agreement with subsidiaries of Gold Fields Limited.
- Calliditas Therapeutics AB (NASDAQ: